Skip Nav Destination
Article navigation
Report|
September 1986
Clinically Significant Muscle Weakness Induced by Oral Dantrolene Sodium Prophylaxis for Malignant Hyperthermia
E. Norfleet
E. Norfleet
*Associate Professor.
Search for other works by this author on:
Anesthesiology September 1986, Vol. 65, 312–314.
Citation
C. Watson, N. Reierson, E. Norfleet; Clinically Significant Muscle Weakness Induced by Oral Dantrolene Sodium Prophylaxis for Malignant Hyperthermia. Anesthesiology 1986; 65:312–314 doi: https://doi.org/10.1097/00000542-198609000-00012
Download citation file:
34
Views
0
Citations
Citing articles via
Most Viewed
Related Articles
Malignant Hyperthermia Testing in Probands without Adverse Anesthetic Reaction
Anesthesiology (September 2015)
Effects of Dantrolene on Rat Diaphragm Muscle during Postnatal Maturation
Anesthesiology (March 2001)
Controversies in Perioperative Antimicrobial Prophylaxis
Anesthesiology (March 2020)
Antiemetic Prophylaxis for Office-based Surgery: Are the 5-HT3Receptor Antagonists Beneficial?
Anesthesiology (February 2003)
In Vitro Effects of Dantrolene on Rat Myocardium
Anesthesiology (January 1997)
